Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06496269 · ClinicalTrials.gov registry record
Impact of Microvascular Inflammation on Kidney Allograft Outcome
A clinical trial, sponsored by Paris Translational Research Center for Organ Transplantation.
- Completed
- Registry status
- 6,000
- Enrollment target
NCT06496269 is a clinical trial that has completed, run by Paris Translational Research Center for Organ Transplantation. The registered enrollment target is 6,000 participants.
The verdict
NCT06496269 has completed, sponsored by Paris Translational Research Center for Organ Transplantation.
- COMPLETED
- Registry status
- 6,000 participants
- Enrollment target
Study Summary
Graft microvascular inflammation poses a significant challenge to successful kidney transplantation due to its heterogeneous clinical presentation. There is a critical need to unravel the clinical significance of newly defined allograft microvascular inflammation phenotypes in the Banff 2022 classification and assess the implications of these new phenotypes on kidney transplant precision diagnostics and patient risk stratification.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,000 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2023-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06496269
The ClinicalTrials.gov registry entry for NCT06496269 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Paris Translational Research Center for Organ Transplantation, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT06496269 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06496269 about?
NCT06496269 is a clinical study titled "Impact of Microvascular Inflammation on Kidney Allograft Outcome". Graft microvascular inflammation poses a significant challenge to successful kidney transplantation due to its heterogeneous clinical presentation. There is a critical need to unravel the clinical significance of newly defined allograft microvascular inflammation phenotypes in the Banff 2022 classif...
What is the current status of trial NCT06496269?
This trial is currently completed. The enrollment target is 6,000 participants. The study started on 2023-01-01. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT06496269?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT06496269?
This trial is sponsored by Paris Translational Research Center for Organ Transplantation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.